Autoimmune diseases have a complex etiology and despite great progress having been made in our comprehension of these disorders, there has been limited success in the development of approved medications based on these insights. Development of drugs and strategies for application in translational research and medicine are hampered by an inadequate molecular definition of the human autoimmune phenotype and the organizational models that are necessary to clarify this definition.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles
Translational Medicine Communications Open Access 18 November 2019
-
Classifying publications from the clinical and translational science award program along the translational research spectrum: a machine learning approach
Journal of Translational Medicine Open Access 05 August 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout




References
National Institutes of Health Research Portfolio Online Reporting Tools http://report.nih.gov (2011).
American Autoimmune Related Disease Association. http://www.aarda.org (2011).
Bach, J.F. N. Engl. J. Med. 347, 911–920 (2002).
National Human Genome Research Institute. http://www.genome.gov/gwastudies/ (2011).
Peterson, D.A., Frank, D.N., Pace, N.R. & Gordon, J.I. Cell Host Microbe 3, 417–427 (2008).
Porter, M.E. Harv. Bus. Rev. (Nov-Dec): 61–78 (1996).
Westfall, J.M., Mold, J. & Fagnan, L. J. Am. Med. Assoc. 297, 403–406 (2007).
Kola, I. & Landis, J. Nat. Rev. Drug Discov. 3, 711–715 (2004).
Reichert, J.M. Curr. Pharm. Biotechnol. 9, 423–430 (2008).
DiMasi, J.A., Feldman, L., Seckler, A. & Wilson, A. Clin. Pharmacol. Ther. 87, 272–277 (2010).
Nelson, A.L., Dhimolea, E. & Reichert, J.M. Nat. Rev. Drug Discov. 9, 767–774 (2010).
Woodcock, J. & Woosley, R. Annu. Rev. Med. 59, 1–12 (2008).
DiMasi, J.A. & Grabowski, H.G. Manage. Decis. Econ. 28, 469–479 (2007).
Kaitin, K.I. & DiMasi, J.A. Clin. Pharmacol. Ther. 89, 183–188 (2011).
Zerhouni, E. Science 302, 63–72 (2003).
Collins, F.S. Sci. Transl. Med. 3, 90cm17 (2011).
Snape, K., Trembath, R.C. & Lord, G.M. QJM 101, 901–906 (2008).
Couzin-Frankel, J. Science 333, 819–821 (2011).
Mestas, J. & Hughes, C.W. J. Immunol. 172, 2731–2738 (2004).
Davis, M.M. Immunity 29, 835–838 (2008).
Kaser, A. et al. Cell 134, 743–756 (2008).
Bettelli, E., Oukka, M. & Kuchroo, V.K.T. Nat. Immunol. 8, 345–350 (2007).
Nussenblatt, R.B. et al. Ann. NY Acad. Sci. 1200, E1–E23 (2010).
Barabasi, A.L., Gulbahce, N. & Loscalzo, J. Nat. Rev. Genet. 12, 56–68 (2011).
Lettre, G. & Rioux, J.D. Hum. Mol. Genet. 17, R116–R121 (2008).
Notarangelo, L.D. et al. J. Allergy Clin. Immunol. 124, 1161–1178 (2009).
Webb, C.P. & Pass, H.I. J. Transl. Med. 2, 35 (2004).
de Bakker, P.I.W. et al. Nat. Genet. 37, 1217–1223 (2005).
Costello, E.K. et al. Science 326, 1694–1697 (2009).
Califf, R.M. & Berglund, L. Acad. Med. 85, 457–462 (2010).
Honey, K. J. Clin. Invest. 121, 3778–3781 (2011).
Soderquest, K. & Lord, G.M. Sci. Transl. Med. 2, 53cm28 (2010).
Ioannidis, J.P. J. Transl. Med. 2, 5 (2004).
von Herrath, M. & Chan, A. J. Clin. Invest. 119, 1061–1065 (2009).
von Herrath, M.G. & Nepom, G.T. J. Exp. Med. 202, 1159–1162 (2005).
Ratner, M. Nat. Biotechnol. 29, 3–4 (2011).
Philipson, L. J. Am. Med. Assoc. 294, 1394–1398 (2005).
Goldman, M. Nat. Rev. Drug Discov. 10, 321–322 (2011).
Sung, N.S. et al. J. Am. Med. Assoc. 289, 1278–1287 (2003).
Cech, T.R. J. Am. Med. Assoc. 294, 1390–1393 (2005).
Loscalzo, J. N. Engl. J. Med. 354, 1665–1667 (2006).
Korn, D. et al. Science 296, 1401–1402 (2002).
Woolley, M. & Propst, S.M. J. Am. Med. Assoc. 294, 1380–1384 (2005).
Thank you, Grover Norquist. Wall St. J. (22 November 22 2011).
The Congress of the United States Congressional Budget Office (October 2006).
Tigue, C.C. et al. Targ. Oncol. 2, 113–119 (2007).
Spear, B.B. et al. Trends Mol. Med. 7, 201–204 (2001).
Sandborn, W.J. N. Engl. J. Med. 353, 1912–1925 (2005).
Owens, J. Nat. Rev. Drug Discov. 6, 99–101 (2007).
Hughes, B. Nat. Rev. Drug Discov. 7, 107–109 (2008).
Hughes, B. Nat. Rev. Drug Discov. 8, 93–96 (2009).
Hughes, B. Nat. Rev. Drug Discov. 9, 89–92 (2010).
Mullard, A. Nat. Rev. Drug Discov. 10, 82–85 (2011).
Finkbeiner, S. Nat. Med. 16, 1227–1232 (2010).
Chan, A.C. & Carter, P.J. Nat. Rev. Immunol. 10, 301–316 (2010).
Roopenian, D.C. & Akilesh, S. Nat. Rev. Immunol. 7, 715–725 (2007).
Anthony, R.M., Wermeling, F., Karlsson, M.C. & Ravetch, J.V. Proc. Natl. Acad. Sci. USA 105, 19571–19578 (2008).
Tanaka, T., Narazaki, M. & Kishimoto, T. FEBS Lett. 585, 3699–3709 (2011).
Benson, J.M. et al. Nat. Biotechnol. 29, 615–624 (2011).
Navarra, S.V. et al. Lancet 377, 721–731 (2011).
Hla, T. & Brinkmann, V. Neurology 76, S3–S8 (2011).
Hirano, T. Nature 324, 73–76 (1986).
Yamasaki, K. Science 241, 825–828 (1988).
Mankoff, S.P., Brander, D., Ferrone, S. & Marincola, F.M. J. Transl. Med. 2, 14 (2004).
Hörig, H., Marincola, E. & Marincola, F.M. Nat. Med. 11, 705–708 (2005).
Littman, B.H., Di Mario, L., Plebani, M. & Marincola, F.M. Clin. Sci. 112, 217–227 (2007).
Mintzberg, H. Harv. Bus. Rev. (Jan-Feb): 103–116 (1981).
Disis, M.L. & Slattery, J.T. Sci. Transl. Med. 2, 22cm9 (2010).
Pyne, S. et al. Proc. Natl. Acad. Sci. USA 106, 8519–8524 (2009).
Maecker, H.T. et al. Nat. Immunol. 11, 975–978 (2010).
Cortes, A. & Brown, M.A. Arthritis Res. Ther. 13, 101 (2011).
Kelly, R.J., Carter, C. & Giaccone, G. J. Clin. Oncol. 28, e507–e510 (2010).
LoRusso, P.M. J. Clin. Oncol. 27, 2586–2588 (2009).
Mannon, P.J. et al. Gut 60, 449–455 (2011).
Kaser, A. & Blumberg, R.S. Gut 60, 430–431 (2011).
Ji, Z., Flaherty, K. T. & Tsao, H. Trends Mol. Med. published online, doi:10.1016/j.molmed.2011.08.001 (30 September 2011).
Azarova, A. M., Gautam, G. & George, R. E. Semin. Cancer Biol. 21, 267–275 (2011).
Acknowledgements
The authors thank T. Rath, C. Pola and L. Paradiso for assistance in assembling data related to recent approvals of therapeutic agents in autoimmunity and assembling the manuscript. R.S.B. was supported by US National Institutes of Health grants DK44319, DK53056, DK51362, DK88199 and the Harvard Digestive Diseases Center (grant DK34854). F.O.N. is supported by a Senior Investigator award of the National Institutes of Health Research, Wellcome Trust Programme grant GR078173MA, Medical Research Council UK Programme grant G0601387 and the UK Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's & St. Thomas' National Health Service Foundation Trust in partnership with King's College London.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Blumberg, R., Dittel, B., Hafler, D. et al. Unraveling the autoimmune translational research process layer by layer. Nat Med 18, 35–41 (2012). https://doi.org/10.1038/nm.2632
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2632
This article is cited by
-
Translational research: from basic research to regional biomedical entrepreneurship
Small Business Economics (2023)
-
Lost in translation: the valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles
Translational Medicine Communications (2019)
-
Translating Behavior Analysis: a Spectrum Rather than a Road Map
Perspectives on Behavior Science (2018)
-
Classifying publications from the clinical and translational science award program along the translational research spectrum: a machine learning approach
Journal of Translational Medicine (2016)
-
Process evaluation and proximal impact of an affect-based exercise intervention among adolescents
Translational Behavioral Medicine (2014)